Traditional Chinese Medicine in Cancer Care: A Review of Controlled Clinical Studies Published in Chinese
Xun Li,Xun Li,Guoyan Yang,Xinxue Li,Yan-Yan Zhang,Jingli Yang,Jiu Li Chang,Xiaoxuan Sun,Xiaoyun Zhou,Yu Guo,Yue Xu,Jianping Liu,Alan Bensoussan +12 more
TLDR
Data from controlled clinical studies of TCM therapies in cancer treatment is substantial, and different therapies are applied either as monotherapy or in combination with conventional medicine.Abstract:
Background
Traditional Chinese medicine (TCM) has been widely applied for cancer care in China. There have been a large number of controlled clinical studies published in Chinese literature, yet no systematic searching and analysis has been done. This study summarizes the current evidence of controlled clinical studies of TCM for cancer.read more
Citations
More filters
Journal ArticleDOI
Existing and potential therapeutic uses for N-acetylcysteine: the need for conversion to intracellular glutathione for antioxidant benefits.
TL;DR: A key conclusion is a reinforcement of the concept that NAC should not be considered to be a powerful antioxidant in its own right: its strength is the targeted replenishment of GSH in deficient cells and it is likely to be ineffective in cells replete in GSH.
Journal ArticleDOI
The amazing potential of fungi: 50 ways we can exploit fungi industrially
Kevin D. Hyde,Jianchu Xu,Jianchu Xu,Sylvie Rapior,Rajesh Jeewon,Saisamorn Lumyong,Allen Grace Niego,Allen Grace Niego,Pranami D. Abeywickrama,Janith V. S. Aluthmuhandiram,Rashika S. Brahamanage,Siraprapa Brooks,Amornrat Chaiyasen,K. W. Thilini Chethana,Putarak Chomnunti,Clara Chepkirui,Boontiya Chuankid,Nimali I. de Silva,Mingkwan Doilom,Mingkwan Doilom,Mingkwan Doilom,Craig B. Faulds,Eleni Gentekaki,Venkat Gopalan,Pattana Kakumyan,Dulanjalee Harishchandra,Hridya Hemachandran,Sinang Hongsanan,Anuruddha Karunarathna,Anuruddha Karunarathna,Samantha C. Karunarathna,Sehroon Khan,Jaturong Kumla,Ruvishika S. Jayawardena,Jian-Kui Liu,Ning-Guo Liu,Thatsanee Luangharn,Allan Patrick G. Macabeo,Diana S. Marasinghe,Dan Meeks,Peter E. Mortimer,Peter E. Mortimer,Peter Mueller,Sadia Nadir,Sadia Nadir,Karaba N. Nataraja,Sureeporn Nontachaiyapoom,Meghan O’Brien,Watsana Penkhrue,Chayanard Phukhamsakda,Uma Shaanker Ramanan,Achala R. Rathnayaka,Resurreccion B. Sadaba,Birthe Sandargo,Binu C. Samarakoon,Danushka S. Tennakoon,Ramamoorthy Siva,Wasan Sriprom,Trichur S. Suryanarayanan,Kanaporn Sujarit,Nakarin Suwannarach,Thitipone Suwunwong,Benjarong Thongbai,Naritsada Thongklang,De-Ping Wei,S. Nuwanthika Wijesinghe,Jake Winiski,Jiye Yan,Erandi Yasanthika,Marc Stadler +69 more
TL;DR: This manuscript reviews fifty ways in which fungi can potentially be utilized as biotechnology and provides a flow chart that can be used to convince funding bodies of the importance of fungi for biotechnological research and as potential products.
Journal ArticleDOI
Challenges to effective cancer control in China, India, and Russia
Paul E. Goss,Kathrin Strasser-Weippl,Brittany L. Lee-Bychkovsky,Brittany L. Lee-Bychkovsky,Lei Fan,Lei Fan,Junjie Li,Junjie Li,Yanin Chavarri-Guerra,Pedro E.R. Liedke,C S Pramesh,Tanja Badovinac-Crnjevic,Yuri Sheikine,Yuri Sheikine,Zhu Chen,You-Lin Qiao,Z Shao,Yi-Long Wu,Daiming Fan,Louis W.C. Chow,Jun Wang,Qiong Zhang,Shiying Yu,Gordon C Shen,Gordon C Shen,Jie He,Arnie Purushotham,Richard Sullivan,Rajendra A. Badwe,Shripad Banavali,Reena Nair,Lalit Kumar,Purvish M. Parikh,Somasundarum Subramanian,Pankaj Chaturvedi,Subramania Iyer,Surendra S Shastri,Raghunadhrao Digumarti,Enrique Soto-Perez-de-Celis,Dauren Adilbay,Vladimir Semiglazov,Sergey Orlov,Dilyara Kaidarova,Ilya Tsimafeyeu,Sergei Tatishchev,Kirill D. Danishevskiy,Marc Hurlbert,Caroline Vail,Jessica St. Louis,A. Chan +49 more
TL;DR: The overall state of health and cancer control in each country is described and additional specific issues for consideration are described: for China, access to care, contamination of the environment, and cancer fatalism and traditional medicine; for India, affordability of care, provision of adequate health personnel, and sociocultural barriers to cancer control.
Journal ArticleDOI
The advantages of using traditional Chinese medicine as an adjunctive therapy in the whole course of cancer treatment instead of only terminal stage of cancer
TL;DR: Current evidence for using TCM as adjuvant cancer treatment in different stages of cancer lesions is summarized to contribute to an understanding of Chinese herbal medicines as an adjunctive therapy in the whole course of cancer treatment instead of only terminal stage of cancer.
Journal ArticleDOI
Biochar-based water treatment systems as a potential low-cost and sustainable technology for clean water provision.
TL;DR: Seven hypotheses for future research are highlighted under three themes: design and optimization of bio char water treatment; ecotoxicology and human health risks associated with contaminant transfer along the biochar-soil-food-human pathway, and life cycle analyses of carbon and energy footprints of biochar water treatment systems.
References
More filters
Journal ArticleDOI
Global cancer statistics
TL;DR: A substantial proportion of the worldwide burden of cancer could be prevented through the application of existing cancer control knowledge and by implementing programs for tobacco control, vaccination, and early detection and treatment, as well as public health campaigns promoting physical activity and a healthier dietary intake.
Journal Article
Cochrane Handbook for Systematic Reviews of Interventions
Journal ArticleDOI
Pharmacological interventions for somatoform disorders in adults.
Maria Kleinstäuber,Michael Witthöft,Andrés Steffanowski,Harm W.J. van Marwijk,Wolfgang Hiller,Michael J. Lambert +5 more
TL;DR: A systematic review and meta-analysis of placebo-controlled studies examined the efficacy and tolerability of different types of antidepressants, the combination of an antidepressant and an antipsychotic, antipsychotics alone, or natural products in adults with somatoform disorders in adults to improve optimal treatment decisions.
Journal ArticleDOI
CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials
TL;DR: The Consort 2010 Statement as discussed by the authors has been used worldwide to improve the reporting of randomised controlled trials and has been updated by Schulz et al. in 2010, based on new methodological evidence and accumulating experience.